Consistently, in both humans and mice models, induction of higher-avidity CD8 T-cell responses promoted more efficient tumor rejection [101, 130] and earlier target cell lysis in the context of viral infection, reducing viral burden more effectively than low-avidity CD8 T cells. This evidence concerns the gene CD8A and neoplasm.